Virus News and Research

Latest Virus News and Research

Vaccine against Ebola developed

Ebola was first identified in 1976 in Sudan and Zaire, which is now the Democratic Republic of the Congo and Ebola fever kills more than 90% of the people it infects. Ebola is among the most lethal diseases known to humans, according to the World Health Organization.

7 Dec 2011

Aethlon receives approval to begin Hemopurifier study at Sarcoma Oncology Center

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that a cancer research study to test the ex vivo effectiveness of the Aethlon Hemopurifier to capture tumor-secreted exosomes from the blood of advanced-stage cancer patients has received institutional review board approval to begin studies at the Sarcoma Oncology Center, based in Santa Monica, California.

7 Dec 2011

Biologists discover how fruit flies can provide solutions to human pain, control insect-borne diseases

Studies of a protein that fruit flies use to sense heat and chemicals may someday provide solutions to human pain and the control of disease-spreading mosquitoes.

7 Dec 2011

Study reveals previously unseen details of SBP8a anthrax bacteriophage

A new study has shown previously unseen details of an anthrax bacteriophage - a virus that infects anthrax bacteria - revealing for the first time how it infects its host, and providing an initial blueprint for how the phage might someday be modified into a tool for the detection and destruction of anthrax and other potential bioterror agents.

6 Dec 2011

Social determinants contribute to incidence of H1N1 virus in U.S. Hispanics during 2009 pandemic

Social determinants, including the lack of paid sick leave, contributed to higher risk of exposure to the influenza A (H1N1) virus among Hispanics in the U.S. during the 2009 H1N1 pandemic, according to a study led by Sandra Crouse Quinn, professor of family science and senior associate director of the Maryland Center for Health Equity at the University of Maryland School of Public Health.

6 Dec 2011

Measles raises its head again in Europe after years of suppression: Report

According to a new report last Thursday, measles incidence is on the rise in Europe following decades of decline. Up to October European health officials reported more than 26,000 measles cases this year and nine deaths.

5 Dec 2011

NanoViricides submits pre-IND Meeting Request for FluCide to FDA

NanoViricides, Inc. announced today that it has submitted a pre-IND Meeting Request to the US FDA. The Company has requested an initial meeting with the US FDA to review the Company's proposed strategy and plan for conducting safety/toxicology studies and human clinical trials required for approval of its anti-influenza clinical drug candidate, FluCide™ (i.e. NV-INF-1).

5 Dec 2011

Plasma can inactivate and prevent replication of adenoviruses

Life-threatening viruses such as HIV, SARS, hepatitis and influenza, could soon be combatted in an unusual manner as researchers have demonstrated the effectiveness of plasma for inactivating and preventing the replication of adenoviruses.

5 Dec 2011

Obama pledges more for fighting HIV/AIDS

On the occasion of World AIDS day on 1st December, President Barack Obama vowed to boost U.S. efforts to fight AIDS with a new target of providing treatment to 6 million people worldwide by 2013, up from an earlier goal of 4 million.

4 Dec 2011

Research roundup: Recession's big impact on men's insurance coverage

Researchers examined three sets of surveillance data and found that of the estimated 1.2 million persons in the United States living with the human immunodeficiency virus, 942,000 persons were aware of their infection. More than three-quarters of those were "linked to care" and among HIV-infected adults in care, "45 percent received prevention counseling, and 89 percent were prescribed antiretroviral therapy."

3 Dec 2011

On World AIDS Day, Obama announces plan to redirect $50 million to fight AIDS

President Barack Obama told advocates, patients and other stakeholders that his administration will do more to get antiretroviral drugs to people infected with HIV - in the United States and in low-income countries around the world.

3 Dec 2011

Bristol-Myers Squibb and Tibotec partner to evaluate daclatasvir-TMC435 combination for HCV

Bristol-Myers Squibb Company announced today that it has entered into a clinical collaboration agreement with Tibotec Pharmaceuticals to evaluate the utility of daclatasvir (BMS-790052), Bristol-Myers Squibb's investigational NS5A replication complex inhibitor, in combination with Tibotec Pharmaceuticals' investigational NS3 protease inhibitor, TMC435, for the treatment of chronic hepatitis C virus (HCV).

3 Dec 2011

Baby boomers more likely to develop HCV

Experts at Montefiore Medical Center urge the general public to be tested for the Hepatitis C virus, especially baby boomers, adults born between 1946-1964, who could be most at risk for this disease. Baby boomers are more likely to have been exposed to dangerous risk factors decades ago, such as sharing a drug needle, being tattooed or pierced with unsterilized tools or receiving a tainted blood transfusion.

2 Dec 2011

Bristol-Myers Squibb, Tibotec partner for TMC435 Phase II combination study in HCV

Medivir AB, the research-based speciality pharmaceutical company focused on the development of high-value treatments for infectious diseases, announces that its development partner, Tibotec Pharmaceuticals, has entered into an agreement with Bristol-Myers Squibb Company.

2 Dec 2011

Treatments for lymphoma with no side effects

Larry Conrad went in for his annual physical on his 50th birthday. During his exam, his doctor found swollen lymph nodes in his armpits and groin. Conrad had a cough and said he'd lost weight because he 'felt full all the time'. His doctor ordered a series of tests, and Conrad was diagnosed with Non-Hodgkin's lymphoma, the most common type.

2 Dec 2011

Longer looks: Life of a Medicare demo project; Broken hearts; AIDS funding

Today's Medicare demonstration project might determine how physicians interact with the program tomorrow, so naturally such projects generate a lot of buzz in the health care community. Lately, some of that buzz has been about how demos might provide part of the solution for Medicare's payment problems.

2 Dec 2011

Obama renews U.S. commitment to ending AIDS in World AIDS Day speech

President Barack Obama on Thursday renewed the U.S. commitment to ending HIV/AIDS in a speech marking World AIDS Day, and was joined by former presidents Bill Clinton, who participated by video, and George W. Bush, who spoke from Tanzania with that country's President, Jakaya Kikwete, the Independent reports.

2 Dec 2011

NAPWA advocates for fighting a three-fronted war against HIV/AIDS

"NAPWA, the largest and oldest advocacy group for people living with HIV/AIDS, advocates for fighting a three-fronted war against HIV/AIDS.

2 Dec 2011

Uncertainty about HIV pushes young Malawians to start families

People in Malawi who are uncertain about their HIV status are more eager to start families than those who are certain of their HIV status, according to researchers.

2 Dec 2011

Viewpoints: Bush, Bono and others reflect on World AIDS Day; Coburn and Burr on Medicare savings

On this Dec. 1, World AIDS Day, the promise of progress against the disease has never been more vivid - or more fragile. ... In lean budget times, the U.S. and the developing world must prioritize. But there can be no higher priority than saving lives. And there is no better way to save lives than to support and expand effective, proven programs such as Pepfar.

2 Dec 2011

Virus News and Research

Latest Virus News and Research

Vaccine against Ebola developed

Aethlon receives approval to begin Hemopurifier study at Sarcoma Oncology Center

Biologists discover how fruit flies can provide solutions to human pain, control insect-borne diseases

Study reveals previously unseen details of SBP8a anthrax bacteriophage

Social determinants contribute to incidence of H1N1 virus in U.S. Hispanics during 2009 pandemic

Measles raises its head again in Europe after years of suppression: Report

NanoViricides submits pre-IND Meeting Request for FluCide to FDA

Plasma can inactivate and prevent replication of adenoviruses

Obama pledges more for fighting HIV/AIDS

Research roundup: Recession's big impact on men's insurance coverage

On World AIDS Day, Obama announces plan to redirect $50 million to fight AIDS

Bristol-Myers Squibb and Tibotec partner to evaluate daclatasvir-TMC435 combination for HCV

Baby boomers more likely to develop HCV

Bristol-Myers Squibb, Tibotec partner for TMC435 Phase II combination study in HCV

Treatments for lymphoma with no side effects

Longer looks: Life of a Medicare demo project; Broken hearts; AIDS funding

Obama renews U.S. commitment to ending AIDS in World AIDS Day speech

NAPWA advocates for fighting a three-fronted war against HIV/AIDS

Uncertainty about HIV pushes young Malawians to start families

Viewpoints: Bush, Bono and others reflect on World AIDS Day; Coburn and Burr on Medicare savings

A new way of characterising biomolecules eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in